Huntington National Bank Grows Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Huntington National Bank boosted its position in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 26.5% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 253 shares of the medical technology company’s stock after acquiring an additional 53 shares during the quarter. Huntington National Bank’s holdings in Teleflex were worth $50,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Venturi Wealth Management LLC bought a new position in Teleflex during the 3rd quarter valued at about $27,000. Pinebridge Investments L.P. bought a new position in Teleflex in the 2nd quarter worth about $700,000. Handelsbanken Fonder AB grew its stake in Teleflex by 9.7% in the 2nd quarter. Handelsbanken Fonder AB now owns 9,395 shares of the medical technology company’s stock worth $2,274,000 after acquiring an additional 830 shares in the last quarter. Machina Capital S.A.S. bought a new position in Teleflex in the 3rd quarter worth about $435,000. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund grew its stake in Teleflex by 172.4% in the 2nd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 12,008 shares of the medical technology company’s stock worth $2,906,000 after acquiring an additional 7,600 shares in the last quarter. 97.15% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

TFX has been the topic of a number of research analyst reports. Raymond James upped their target price on shares of Teleflex from $227.00 to $271.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 20th. Morgan Stanley upgraded shares of Teleflex from an “equal weight” rating to an “overweight” rating and set a $261.00 target price on the stock in a research note on Monday, December 4th. JMP Securities dropped their target price on shares of Teleflex from $315.00 to $285.00 and set a “market outperform” rating on the stock in a research note on Friday, November 3rd. Stephens restated an “overweight” rating and issued a $275.00 target price on shares of Teleflex in a research note on Friday, November 3rd. Finally, Royal Bank of Canada upped their target price on shares of Teleflex from $228.00 to $272.00 and gave the stock an “outperform” rating in a research note on Friday, January 12th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $269.30.

View Our Latest Research Report on Teleflex

Insider Activity at Teleflex

In related news, CEO Liam Kelly sold 26,256 shares of the stock in a transaction that occurred on Wednesday, December 27th. The shares were sold at an average price of $250.23, for a total transaction of $6,570,038.88. Following the completion of the sale, the chief executive officer now owns 18,470 shares of the company’s stock, valued at $4,621,748.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CFO Thomas E. Powell sold 13,952 shares of the stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $222.88, for a total transaction of $3,109,621.76. Following the completion of the sale, the chief financial officer now owns 14,384 shares of the company’s stock, valued at $3,205,905.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Liam Kelly sold 26,256 shares of the firm’s stock in a transaction on Wednesday, December 27th. The stock was sold at an average price of $250.23, for a total transaction of $6,570,038.88. Following the completion of the transaction, the chief executive officer now directly owns 18,470 shares of the company’s stock, valued at approximately $4,621,748.10. The disclosure for this sale can be found here. 1.41% of the stock is currently owned by corporate insiders.

Teleflex Trading Up 0.3 %

NYSE:TFX opened at $252.73 on Tuesday. Teleflex Incorporated has a 52 week low of $177.63 and a 52 week high of $276.43. The firm has a 50 day moving average of $246.20 and a 200 day moving average of $222.86. The company has a quick ratio of 2.51, a current ratio of 3.58 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $11.88 billion, a price-to-earnings ratio of 29.63, a PEG ratio of 2.29 and a beta of 1.14.

Teleflex Company Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Read More

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.